KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Income from Continuing Operations (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Income from Continuing Operations for 11 consecutive years, with 135133000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations rose 15.48% year-over-year to 135133000.0, compared with a TTM value of 451123000.0 through Dec 2025, up 11.56%, and an annual FY2025 reading of 451123000.0, up 11.56% over the prior year.
  • Income from Continuing Operations was 135133000.0 for Q4 2025 at Medpace Holdings, up from 111135000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 135133000.0 in Q4 2025 and bottomed at 39669000.0 in Q2 2021.
  • Average Income from Continuing Operations over 5 years is 78210300.0, with a median of 71722000.0 recorded in 2023.
  • Peak annual rise in Income from Continuing Operations hit 64.57% in 2021, while the deepest fall reached 8.53% in 2021.
  • Year by year, Income from Continuing Operations stood at 50034000.0 in 2021, then soared by 37.25% to 68670000.0 in 2022, then increased by 14.02% to 78298000.0 in 2023, then skyrocketed by 49.45% to 117018000.0 in 2024, then grew by 15.48% to 135133000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for MEDP at 135133000.0 in Q4 2025, 111135000.0 in Q3 2025, and 90260000.0 in Q2 2025.